FMR LLC and Abigail P. Johnson filed Amendment No. 10 to a Schedule 13G with the SEC on November 4, 2026, disclosing their beneficial ownership of common stock in Legend Biotech Corp as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: FMR LLC and Abigail P. Johnson each reported beneficial ownership of 48,164,807.69 shares of Legend Biotech Corp common stock.
  • Percent of class: The reported holdings represent 12.4% of Legend Biotech Corp's outstanding common stock.
  • Sole voting power: FMR LLC reported sole voting power over 47,564,475.60 shares; Abigail P. Johnson reported sole voting power over 0.00 shares.
  • Sole dispositive power: Both FMR LLC and Abigail P. Johnson each reported sole dispositive power over 48,164,807.69 shares, with no shared dispositive power.
  • Event date: The date of the event requiring this filing was September 30, 2026.
  • Third-party interest: According to the filing, one or more other persons are known to have the right to receive or direct receipt of dividends or sale proceeds, but no single other person holds more than 5% of the total outstanding common stock.

FMR LLC and Abigail P. Johnson Disclose Ownership Position in Legend Biotech

FMR LLC, a Delaware-organized holding company, and Abigail P. Johnson, a United States citizen, jointly filed Amendment No. 10 to a Schedule 13G disclosing their ownership of common stock in Legend Biotech Corp (CUSIP 52490G102). The filing, signed November 4, 2026, covers ownership as of the event date of September 30, 2026. Legend Biotech Corp's principal executive offices are listed at 2101 Cottontail Lane, Somerset, NJ 08873, and FMR LLC's principal business office is at 245 Summer Street, Boston, Massachusetts 02210.

According to the filing, FMR LLC reported aggregate beneficial ownership of 48,164,807.69 shares, representing 12.4% of the class. FMR LLC holds sole voting power over 47,564,475.60 shares and sole dispositive power over 48,164,807.69 shares, with no shared voting or dispositive power reported. Abigail P. Johnson is listed separately as a reporting person with the same aggregate beneficial ownership figure of 48,164,807.69 shares and 12.4% of the class, attributable entirely to sole dispositive power, while her sole and shared voting power are both reported as 0.00.

The filing states that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." FMR LLC is classified as a parent holding company (type HC) and Abigail P. Johnson as an individual (type IN). The filing references an attached Exhibit 99 identifying relevant subsidiaries of FMR LLC that acquired the reported securities.

What Was Disclosed

FMR LLC and Abigail P. Johnson filed Amendment No. 10 to Schedule 13G reporting combined beneficial ownership of 48,164,807.69 shares, or 12.4%, of Legend Biotech Corp common stock, as of September 30, 2026, with no shared voting or dispositive power reported.